tiprankstipranks
Trending News
More News >
GT Biopharma (GTBP)
NASDAQ:GTBP
US Market

GT Biopharma (GTBP) Financial Statements

Compare
298 Followers

GT Biopharma Financial Overview

GT Biopharma's market cap is currently $7.93M. The company's EPS TTM is $-0.83; its P/E ratio is -0.22; GT Biopharma is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-0.22. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -14.36M$ -13.58M$ -21.26M$ -57.52M$ -6.76M
EBITDA$ -13.16M$ 5.98M$ -20.96M$ -57.48M$ -24.97M
Net Income$ -13.16M$ -7.60M$ -20.88M$ -58.01M$ -28.30M
Balance Sheet
Cash & Short-Term Investments$ 3.95M$ 13.97M$ 16.51M$ 31.98M$ 5.30M
Total Assets$ 4.23M$ 14.11M$ 16.74M$ 32.17M$ 5.66M
Total Debt$ 0.00$ 58.00K$ 174.00K$ 31.00K$ 26.33M
Net Debt$ -3.95M$ -1.02M$ -5.50M$ -8.94M$ 21.04M
Total Liabilities$ 5.90M$ 6.63M$ 5.00M$ 10.26M$ 35.09M
Stockholders' Equity$ -1.67M$ 7.48M$ 11.73M$ 21.91M$ -29.26M
Cash Flow
Free Cash Flow$ -12.90M$ -8.85M$ -15.22M$ -15.61M$ -7.26M
Operating Cash Flow$ -12.90M$ -8.85M$ -15.22M$ -15.61M$ -7.26M
Investing Cash Flow$ 12.89M$ -2.01M$ 12.14M$ -23.04M$ 0.00
Financing Cash Flow$ 2.98M$ 6.27M$ -224.00K$ 42.32M$ 12.53M
Currency in USD

GT Biopharma Earnings and Revenue History

GT Biopharma Debt to Assets

GT Biopharma Cash Flow

GT Biopharma Forecast EPS vs Actual EPS